These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9878876)

  • 1. The NSAID dexketoprofen trometamol is as potent as mu-opioids in the depression of wind-up and spinal cord nociceptive reflexes in normal rats.
    Mazario J; Roza C; Herrero JF
    Brain Res; 1999 Jan; 816(2):512-7. PubMed ID: 9878876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subeffective doses of dexketoprofen trometamol enhance the potency and duration of fentanyl antinociception.
    Gaitán G; Herrero JF
    Br J Pharmacol; 2002 Jan; 135(2):393-8. PubMed ID: 11815374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central and peripheral actions of the NSAID ketoprofen on spinal cord nociceptive reflexes.
    Herrero JF; Parrado A; Cervero F
    Neuropharmacology; 1997 Oct; 36(10):1425-31. PubMed ID: 9423930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
    Herrero JF; Headley PM
    Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical and clinical development of dexketoprofen.
    Mauleón D; Artigas R; García ML; Carganico G
    Drugs; 1996; 52 Suppl 5():24-45; discussion 45-6. PubMed ID: 8922555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subanalgesic doses of dexketoprofen and HCT-2037 (nitrodexketoprofen) enhance fentanyl antinociception in monoarthritic rats.
    Gaitan G; Herrero JF
    Pharmacol Biochem Behav; 2005 Feb; 80(2):327-32. PubMed ID: 15680185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low doses of nitroparacetamol or dexketoprofen trometamol enhance fentanyl antinociceptive activity.
    Gaitán G; Del Soldato P; Herrero JF
    Eur J Pharmacol; 2003 Nov; 481(2-3):181-8. PubMed ID: 14642784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulus intensity and the comparative efficacy of mu- and kappa-opioid agonists on nociceptive spinal reflexes in the rat.
    Thorn SA; Herrero JF; Headley PM
    Brain Res; 1994 Nov; 663(2):352-6. PubMed ID: 7874523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the antinociceptive activity of two new NO-releasing derivatives of the NSAID S-ketoprofen in rats.
    Gaitan G; Ahuir FJ; Del Soldato P; Herrero JF
    Br J Pharmacol; 2004 Nov; 143(5):533-40. PubMed ID: 15451773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antinociceptive effect of the mu-opioid fentanyl is reduced in the presence of the alpha(2)-adrenergic antagonist idazoxan in inflammation.
    Herrero JF; Solano RE
    Brain Res; 1999 Sep; 840(1-2):106-14. PubMed ID: 10517958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of agmatine on spinal nociceptive reflexes: lack of interaction with alpha2-adrenoceptor or mu-opioid receptor mechanisms.
    Bradley KJ; Headley PM
    Eur J Pharmacol; 1997 Jul; 331(2-3):133-8. PubMed ID: 9274971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
    Parsons CG; West DC; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal by naloxone of the spinal antinociceptive actions of a systemically-administered NSAID.
    Herrero JF; Headley PM
    Br J Pharmacol; 1996 Jun; 118(4):968-72. PubMed ID: 8799570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel analgesic and high-efficacy 5-HT1A receptor agonist F 13640 inhibits nociceptive responses, wind-up, and after-discharges in spinal neurons and withdrawal reflexes.
    You HJ; Colpaert FC; Arendt-Nielsen L
    Exp Neurol; 2005 Jan; 191(1):174-83. PubMed ID: 15589524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus.
    Parsons CG; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):523-32. PubMed ID: 2555011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of dexketoprofen.
    Barbanoj MJ; Antonijoan RM; Gich I
    Clin Pharmacokinet; 2001; 40(4):245-62. PubMed ID: 11368291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the selectivity of intravenous mu- and kappa-opioids between nociceptive and non-nociceptive reflexes in the spinalized rat.
    Parsons CG; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):544-51. PubMed ID: 2555013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats.
    Dong XW; Parsons CG; Headley PM
    Br J Pharmacol; 1991 May; 103(1):1230-6. PubMed ID: 1652344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic, antiinflammatory, and antipyretic effects of S(+)-ketoprofen in vivo.
    Cabré F; Fernández MF; Calvo L; Ferrer X; García ML; Mauleón D
    J Clin Pharmacol; 1998 Dec; 38(S1):3S-10S. PubMed ID: 9882076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of IV dexketoprofen trometamol, fentanyl, and paracetamol in the treatment of renal colic in the ED: A randomized controlled trial.
    Al B; Sunar MM; Zengin S; Sabak M; Bogan M; Can B; Kul S; Murat Oktay M; Eren SH
    Am J Emerg Med; 2018 Apr; 36(4):571-576. PubMed ID: 29029797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.